NO20044152L - Farmasoytisk preparat som inneholder vannloselige prodrugs av propofol samt fremgangsmater til administrering av samme - Google Patents

Farmasoytisk preparat som inneholder vannloselige prodrugs av propofol samt fremgangsmater til administrering av samme

Info

Publication number
NO20044152L
NO20044152L NO20044152A NO20044152A NO20044152L NO 20044152 L NO20044152 L NO 20044152L NO 20044152 A NO20044152 A NO 20044152A NO 20044152 A NO20044152 A NO 20044152A NO 20044152 L NO20044152 L NO 20044152L
Authority
NO
Norway
Prior art keywords
propofol
administering
methods
same
containing water
Prior art date
Application number
NO20044152A
Other languages
English (en)
Norwegian (no)
Inventor
Peggy Wingard
Eric S Burak
Ekaterina Gibiansky
James Vornov
Original Assignee
Guilford Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29254399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044152(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Guilford Pharm Inc filed Critical Guilford Pharm Inc
Publication of NO20044152L publication Critical patent/NO20044152L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20044152A 2002-04-08 2004-09-30 Farmasoytisk preparat som inneholder vannloselige prodrugs av propofol samt fremgangsmater til administrering av samme NO20044152L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37021302P 2002-04-08 2002-04-08
US37024502P 2002-04-08 2002-04-08
PCT/US2003/010540 WO2003086413A1 (en) 2002-04-08 2003-04-08 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same

Publications (1)

Publication Number Publication Date
NO20044152L true NO20044152L (no) 2005-01-07

Family

ID=29254399

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044152A NO20044152L (no) 2002-04-08 2004-09-30 Farmasoytisk preparat som inneholder vannloselige prodrugs av propofol samt fremgangsmater til administrering av samme

Country Status (17)

Country Link
US (1) US20050203068A1 (ru)
EP (2) EP1492544A4 (ru)
JP (2) JP5188003B2 (ru)
KR (2) KR20070087004A (ru)
CN (1) CN1649597A (ru)
AU (2) AU2003224851B2 (ru)
BR (1) BR0308857A (ru)
CA (1) CA2480881C (ru)
HU (1) HUP0600241A2 (ru)
IL (2) IL164217A0 (ru)
MX (1) MXPA04009703A (ru)
NO (1) NO20044152L (ru)
NZ (1) NZ535484A (ru)
PL (1) PL373850A1 (ru)
RU (1) RU2297216C2 (ru)
WO (1) WO2003086413A1 (ru)
ZA (1) ZA200407804B (ru)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2543588T3 (es) 2002-12-03 2015-08-20 Pharmacyclics Llc Derivados de 2-(2-hidroxibifenil-3-il)-1H-benzoimidazol-5-carboxamidina como inhibidores del factor VIIa
US8729117B2 (en) 2004-06-02 2014-05-20 Pharmacyclics, Inc. Factor VIIa inhibitor
EP1791521A4 (en) * 2004-09-17 2009-10-21 Eisai Corp North America METHODS OF ADMINISTERING PROPOFOL PROMOTERS WITH WATER SOLUBLE
CN101247809A (zh) * 2005-07-12 2008-08-20 Mgigp公司 用于诱导轻度至中度镇静水平的丙泊酚前药定量给药方法
WO2007131070A2 (en) * 2006-05-04 2007-11-15 Xenoport, Inc. Compositions, dosage forms and methods of treating emesis
KR100755872B1 (ko) * 2006-10-02 2007-09-05 충남대학교산학협력단 미다졸람을 함유하는 염증 예방 및 치료용 약제학적 조성물
KR20090059136A (ko) * 2006-10-05 2009-06-10 에이자이 코포레이션 오브 노쓰아메리카 프로포폴의 수용성 프로드럭의 수성 약제학적 제제
WO2008052044A2 (en) * 2006-10-26 2008-05-02 Xenoport, Inc. Use of derivatives of propofol for treating diseases associated with oxidative stress
ATE540010T1 (de) 2007-05-09 2012-01-15 Pharmacofore Inc Therapeutische verbindungen
JP5651009B2 (ja) 2007-05-09 2015-01-07 ソウッド ヘルスケア エルエルシー 治療用化合物
WO2008157627A1 (en) * 2007-06-21 2008-12-24 Xenoport, Inc. Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus
WO2009036322A1 (en) * 2007-09-14 2009-03-19 Xenoport, Inc. Use of propofol prodrugs for treating neuropathic pain
WO2009052323A2 (en) * 2007-10-16 2009-04-23 Pharmacyclics, Inc. Manufacture, compositions and uses of coagulationfactor viia modulator
UY34072A (es) 2011-05-17 2013-01-03 Novartis Ag Derivados sustituidos de indol
CN102397246A (zh) * 2011-11-18 2012-04-04 陕西合成药业有限公司 一种注射用磷丙泊酚钠及其制备方法和用途
CN103172658B (zh) * 2011-12-26 2016-01-20 宜昌人福药业有限责任公司 一种适合药用的前体药物晶型、制备方法及药用组合物
CN102552291A (zh) * 2012-01-04 2012-07-11 陕西合成药业有限公司 一种磷丙泊酚钠静脉给药制剂及其制备方法和用途
RU2535001C1 (ru) * 2013-07-11 2014-12-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Микроколлоидный раствор пропофола для анестезии
AU2016298280A1 (en) * 2015-07-28 2018-02-22 Beta Cat Pharmaceuticals, Inc. Anthracene-9, 10-dione dioxime compounds prodrugs and their uses
US9585867B2 (en) * 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US11547714B2 (en) 2020-02-05 2023-01-10 Epalex Corporation Fospropofol salts, methods and compositions
US11439653B1 (en) 2021-03-30 2022-09-13 Epalex Corporation Fospropofol formulations
US11628178B2 (en) 2019-03-26 2023-04-18 Epalex Corporation Fospropofol methods and compositions
US11478490B1 (en) 2021-03-30 2022-10-25 Epalex Corporation Fospropofol formulations
CN111135304A (zh) * 2020-01-19 2020-05-12 李启芳 治疗慢性、顽固性或原发性失眠症的联合用药物及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2829151A (en) * 1952-11-03 1958-04-01 Dow Chemical Co Chlorotoloxy-ethyl phosphates
US3271314A (en) * 1958-12-04 1966-09-06 Ethyl Corp 2, 6-diisopropylphenol
GB1146173A (en) * 1966-06-18 1969-03-19 Geigy Uk Ltd Production of triaryl phosphates
US3723578A (en) * 1970-10-13 1973-03-27 Gaf Corp Phosphate esters of ethers of thiol substituted phenols
US4171272A (en) * 1977-12-02 1979-10-16 Fmc Corporation Turbine lubricant
FR2601259B1 (fr) * 1986-07-11 1990-06-22 Rhone Poulenc Chimie Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives.
MY103951A (en) * 1988-01-12 1993-10-30 Kao Corp Detergent composition
FR2638168A1 (fr) * 1988-10-21 1990-04-27 Rhone Poulenc Chimie Dispersions d'halogenures de terres rares en milieu huileux
DE3900941A1 (de) * 1989-01-14 1990-07-19 Henkel Kgaa Verfahren zur flotation von fuellstoffen aus altpapieren in gegenwart organischer phosphorsaeureester
CA2014539C (en) * 1989-04-17 2000-07-25 Shinichiro Umeda Water borne metallic coating composition
US5091211A (en) * 1989-08-17 1992-02-25 Lord Corporation Coating method utilizing phosphoric acid esters
US5110503A (en) * 1990-05-15 1992-05-05 Elliot Cohen Demulsifying
AU660918B2 (en) * 1990-10-17 1995-07-13 Arysta Lifescience Corporation Method and composition for enhancing uptake and transport of bioactive agents in plants
US5646176A (en) * 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
IT1270093B (it) * 1994-09-28 1997-04-28 Zambon Spa Processo per la purificazione di 2,6-diisopropilfenolo
US5804682A (en) * 1995-11-29 1998-09-08 Henkel Corporation Aqueous dispersions of polyamides
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
US5723538A (en) * 1996-06-14 1998-03-03 Henkel Corporation Aqueous dispersions of polyamides
US5746973A (en) * 1996-07-10 1998-05-05 Naraghi; Ali Method for reducing odorant depletion
CA2319810C (en) * 1998-02-10 2008-12-23 Gensia Sicor Inc. Propofol composition containing sulfite
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US6254853B1 (en) * 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
AU750050B2 (en) * 1998-06-03 2002-07-11 Scott Laboratories, Inc. Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
ES2211151T3 (es) * 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
EP1161226B1 (en) * 1999-02-18 2004-05-26 SuperGen, Inc. Phosphocholine linked prodrug derivatives
AU3898700A (en) * 1999-03-15 2000-10-04 John Claude Krusz Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
SE0001865D0 (sv) * 2000-05-19 2000-05-19 Astrazeneca Ab Management of septic shock
CA2412905A1 (en) * 2000-06-16 2001-12-27 Rtp Pharma Inc. Improved injectable dispersions of propofol
US6362234B1 (en) * 2000-08-15 2002-03-26 Vyrex Corporation Water-soluble prodrugs of propofol for treatment of migrane

Also Published As

Publication number Publication date
CA2480881C (en) 2012-09-11
CN1649597A (zh) 2005-08-03
US20050203068A1 (en) 2005-09-15
RU2297216C2 (ru) 2007-04-20
IL164217A0 (en) 2005-12-18
JP2010195803A (ja) 2010-09-09
AU2003224851B2 (en) 2008-04-03
JP5188003B2 (ja) 2013-04-24
PL373850A1 (en) 2005-09-19
KR20040095352A (ko) 2004-11-12
AU2003224851A1 (en) 2003-10-27
CA2480881A1 (en) 2003-10-23
BR0308857A (pt) 2005-01-04
NZ535484A (en) 2009-01-31
KR20070087004A (ko) 2007-08-27
EP1492544A1 (en) 2005-01-05
ZA200407804B (en) 2005-11-30
RU2004129339A (ru) 2005-05-27
EP2281565A2 (en) 2011-02-09
WO2003086413A1 (en) 2003-10-23
AU2008202880A1 (en) 2008-07-24
EP2281565A3 (en) 2011-10-26
IL164217A (en) 2013-02-28
HUP0600241A2 (en) 2006-07-28
MXPA04009703A (es) 2004-12-13
JP2005526108A (ja) 2005-09-02
EP1492544A4 (en) 2005-10-12

Similar Documents

Publication Publication Date Title
NO20044152L (no) Farmasoytisk preparat som inneholder vannloselige prodrugs av propofol samt fremgangsmater til administrering av samme
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
NO20120150L (no) Bifenylderivat, farmasoytisk sammensetning omfattende samme samt anvendelse av samme til behandling av en pulmonal lidelse
NO20033143D0 (no) Farmasoytisk preparat
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
NO20035220D0 (no) Karboksamidsubstituerte fenylureaderivater og fremgangsmåter for fremstilling av disse som legemidler
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
NO20042694L (no) 17 alfa-alkyl-17 beta-oksy-ostratriener og mellomprodukter for fremstilling av disse, anvendelse av 17 alfa-alkyl-17 beta-oksy-ostratrienene til fremstilling av legemidler samt farmasoytiske preparater
IS8327A (is) Módafíníl breyttar losaðar lyfjasamsetningar
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
DE60317887D1 (de) System zur verabreichung therapeutischer substanzen
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl
TWI319317B (en) Modified release pharmaceutical formulation
NO20033042L (no) Cyklodekstrin-inneholdende farmasöytisk preparat
NO20044722L (no) Hoy dose av ibandronat formulering
NO20043333L (no) Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem
ATE290366T1 (de) Pharmazeutische formulierung mit überdecktem geschmack und verfahren zu ihrer herstellung
NO20044132L (no) Legemidler som inneholder aktive ingredienser som senker kolesterolnivaet med tidsforsinket frigjoring av det aktive middelet
NO20043576L (no) Pharmaceutical formulation comprising melatonin
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
AU2003252493A1 (en) Pharmaceutical composition containing decoy and method of using the same
DK1273301T3 (da) Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration
DK1768988T3 (da) Hidtil ukendte phenyl-borsyre-derivater samt fremgangsmåder til fremstilling deraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application